Global Wolff Parkinson White Syndrome Market Size, Share, Forecast Report, 2020-2027

Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than normal heartbeats). WPW is congenital but, symptoms may not become apparent until adolescent. Approximately 10 to 20 % of individuals with WPW syndrome have a congenital heart defect, such as Ebstein’s anomaly. The disorder’s estimated prevalence is -3 people per 1,000 people in the United States.

The symptoms associated with WPW syndrome are irregular heartbeats especially supraventricular tachycardia, palpitations, dyspnea, chest pain, fatigue, atrial flutter, ventricular fibrillation, atrial fibrillation, anxiety, dizziness etc. These symptoms may result in cardiac arrest and sudden death.

The exact cause of WPW syndrome is unknown however genetic mutations and abnormal genes are the most suspected causes. WPW syndrome is often present at birth (congenital), but may not be detected until adolescence or later. Peak incidence has been reported in individuals between 30 and 40 years old in otherwise healthy adults.
The global Wolff Parkinson White syndrome market is expected to reach US$ 1.2 billion by 2023, and the market is projected to grow at a CAGR of ~ 3.3 % during the forecast period 2017-2023.

The market drivers for Wolff Parkinson White syndrome are increasing screening for genetic diseases, rising awareness and growing income of people etc. The market restraints can be poor cure rates, poor efficacy and effectiveness drugs etc.
Key Players in the Global Wolff Parkinson White syndrome Market
Some of key players profiled in the report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, Sanofi S.A., and Novartis International AG, and others.
Market Segments:
The global Wolff Parkinson White syndrome market has been segmented on the basis of types, diagnosis, treatment and end users.

Based on types, the market has been segmented as type A and type B.

Based on diagnosis, the market has been segmented as Electrocardiogram (ECG), Electrophysiological testing, and others.

Based on treatment, the market has been segmented as drugs, cardioversion, radiofrequency catheter ablation, surgery, artificial pacemaker and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic & research and others.